ARA Woodbridge Dialysis Center is a medicare approved dialysis facility center in Woodbridge, New Jersey and it has 19 dialysis stations. It is located in Middlesex county at 345 Main Street, Woodbridge, NJ, 07095. You can reach out to the office of ARA Woodbridge Dialysis Center at (732) 855-2100. This dialysis clinic is managed and/or owned by American Renal Associates. ARA Woodbridge Dialysis Center has the following ownership type - Profit. It was first certified by medicare in February, 2015. The medicare id for this facility is 312647 and it accepts patients under medicare ESRD program.
| Name | ARA Woodbridge Dialysis Center |
|---|---|
| Location | 345 Main Street, Woodbridge, New Jersey |
| No. of Dialysis Stations | 19 |
| Medicare ID | 312647 |
| Managed By | American Renal Associates |
| Ownership Type | Profit |
| Late Shifts | No |
| 345 Main Street, Woodbridge, New Jersey, 07095 | |
| (732) 855-2100 | |
News Archive
BioCryst Pharmaceuticals, Inc. today announced that it has signed agreements with two additional partners who will exclusively represent BioCryst and its anti-viral peramivir for influenza stockpiling opportunities for territories outside of the U.S. BioCryst's new partners are Merck Serono for Europe, Russia, Canada and Singapore and Hikma Pharmaceuticals PLC for the Middle East and North Africa (MENA) region, excluding Israel.
DePuy Synthes today announced the availability of Continuous Compression Implants to health care providers across Europe, the Middle East and Africa. The implants are designed to provide continuous, active compression throughout the healing process to treat a variety of reconstructive foot and ankle procedures, and provide more solutions for our patients and customers.
Premenopausal women who have type 1 diabetes should strongly consider preventive screening for osteoporosis, the researchers of a new study on bone density conclude in the February issue of Diabetes Care.
Top-notch molecular research swung into gear at Texas A&M University this week - literally. A crane lowered a high-field 800 megahertz Nuclear Magnetic Resonance spectrometer through an opening in the roof of a biochemistry and biophysics building Wednesday, putting the university on par with leading U.S. research institutions, according to Dr. Gregory Reinhart, department head.
› Verified 2 days ago
| NPI Number | 1558775536 |
| Organization Name | Garden State Kidney Center |
| Doing Business As | Woodbridge Dialysis Center Llc |
| Address | 345 Main St Woodbridge, New Jersey, 07095 |
| Phone Number | (732) 855-2100 |
News Archive
BioCryst Pharmaceuticals, Inc. today announced that it has signed agreements with two additional partners who will exclusively represent BioCryst and its anti-viral peramivir for influenza stockpiling opportunities for territories outside of the U.S. BioCryst's new partners are Merck Serono for Europe, Russia, Canada and Singapore and Hikma Pharmaceuticals PLC for the Middle East and North Africa (MENA) region, excluding Israel.
DePuy Synthes today announced the availability of Continuous Compression Implants to health care providers across Europe, the Middle East and Africa. The implants are designed to provide continuous, active compression throughout the healing process to treat a variety of reconstructive foot and ankle procedures, and provide more solutions for our patients and customers.
Premenopausal women who have type 1 diabetes should strongly consider preventive screening for osteoporosis, the researchers of a new study on bone density conclude in the February issue of Diabetes Care.
Top-notch molecular research swung into gear at Texas A&M University this week - literally. A crane lowered a high-field 800 megahertz Nuclear Magnetic Resonance spectrometer through an opening in the roof of a biochemistry and biophysics building Wednesday, putting the university on par with leading U.S. research institutions, according to Dr. Gregory Reinhart, department head.
› Verified 2 days ago
| Dialysis patients with Hemoglobin data | 18 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 56 |
News Archive
BioCryst Pharmaceuticals, Inc. today announced that it has signed agreements with two additional partners who will exclusively represent BioCryst and its anti-viral peramivir for influenza stockpiling opportunities for territories outside of the U.S. BioCryst's new partners are Merck Serono for Europe, Russia, Canada and Singapore and Hikma Pharmaceuticals PLC for the Middle East and North Africa (MENA) region, excluding Israel.
DePuy Synthes today announced the availability of Continuous Compression Implants to health care providers across Europe, the Middle East and Africa. The implants are designed to provide continuous, active compression throughout the healing process to treat a variety of reconstructive foot and ankle procedures, and provide more solutions for our patients and customers.
Premenopausal women who have type 1 diabetes should strongly consider preventive screening for osteoporosis, the researchers of a new study on bone density conclude in the February issue of Diabetes Care.
Top-notch molecular research swung into gear at Texas A&M University this week - literally. A crane lowered a high-field 800 megahertz Nuclear Magnetic Resonance spectrometer through an opening in the roof of a biochemistry and biophysics building Wednesday, putting the university on par with leading U.S. research institutions, according to Dr. Gregory Reinhart, department head.
› Verified 2 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 30 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 293 |
| Percentage of adult patients getting regular hemodialysis at the center | 99 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
BioCryst Pharmaceuticals, Inc. today announced that it has signed agreements with two additional partners who will exclusively represent BioCryst and its anti-viral peramivir for influenza stockpiling opportunities for territories outside of the U.S. BioCryst's new partners are Merck Serono for Europe, Russia, Canada and Singapore and Hikma Pharmaceuticals PLC for the Middle East and North Africa (MENA) region, excluding Israel.
DePuy Synthes today announced the availability of Continuous Compression Implants to health care providers across Europe, the Middle East and Africa. The implants are designed to provide continuous, active compression throughout the healing process to treat a variety of reconstructive foot and ankle procedures, and provide more solutions for our patients and customers.
Premenopausal women who have type 1 diabetes should strongly consider preventive screening for osteoporosis, the researchers of a new study on bone density conclude in the February issue of Diabetes Care.
Top-notch molecular research swung into gear at Texas A&M University this week - literally. A crane lowered a high-field 800 megahertz Nuclear Magnetic Resonance spectrometer through an opening in the roof of a biochemistry and biophysics building Wednesday, putting the university on par with leading U.S. research institutions, according to Dr. Gregory Reinhart, department head.
› Verified 2 days ago
| Adult patients getting regular peritoneal dialysis at the center | 3 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 36 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
BioCryst Pharmaceuticals, Inc. today announced that it has signed agreements with two additional partners who will exclusively represent BioCryst and its anti-viral peramivir for influenza stockpiling opportunities for territories outside of the U.S. BioCryst's new partners are Merck Serono for Europe, Russia, Canada and Singapore and Hikma Pharmaceuticals PLC for the Middle East and North Africa (MENA) region, excluding Israel.
DePuy Synthes today announced the availability of Continuous Compression Implants to health care providers across Europe, the Middle East and Africa. The implants are designed to provide continuous, active compression throughout the healing process to treat a variety of reconstructive foot and ankle procedures, and provide more solutions for our patients and customers.
Premenopausal women who have type 1 diabetes should strongly consider preventive screening for osteoporosis, the researchers of a new study on bone density conclude in the February issue of Diabetes Care.
Top-notch molecular research swung into gear at Texas A&M University this week - literally. A crane lowered a high-field 800 megahertz Nuclear Magnetic Resonance spectrometer through an opening in the roof of a biochemistry and biophysics building Wednesday, putting the university on par with leading U.S. research institutions, according to Dr. Gregory Reinhart, department head.
› Verified 2 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at ARA Woodbridge Dialysis Center with elevated calcium levels.
| Patients with hypercalcemia | 35 |
| Hypercalcemia patient months | 353 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 39 |
| Patients with Serumphosphor less than 3.5 mg/dL | 4 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 38 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 44 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 10 |
| Patients with Serumphosphor greater than 7 mg/dL | 4 |
News Archive
BioCryst Pharmaceuticals, Inc. today announced that it has signed agreements with two additional partners who will exclusively represent BioCryst and its anti-viral peramivir for influenza stockpiling opportunities for territories outside of the U.S. BioCryst's new partners are Merck Serono for Europe, Russia, Canada and Singapore and Hikma Pharmaceuticals PLC for the Middle East and North Africa (MENA) region, excluding Israel.
DePuy Synthes today announced the availability of Continuous Compression Implants to health care providers across Europe, the Middle East and Africa. The implants are designed to provide continuous, active compression throughout the healing process to treat a variety of reconstructive foot and ankle procedures, and provide more solutions for our patients and customers.
Premenopausal women who have type 1 diabetes should strongly consider preventive screening for osteoporosis, the researchers of a new study on bone density conclude in the February issue of Diabetes Care.
Top-notch molecular research swung into gear at Texas A&M University this week - literally. A crane lowered a high-field 800 megahertz Nuclear Magnetic Resonance spectrometer through an opening in the roof of a biochemistry and biophysics building Wednesday, putting the university on par with leading U.S. research institutions, according to Dr. Gregory Reinhart, department head.
› Verified 2 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 31 |
| Patient months included in arterial venous fistula and catheter summaries | 275 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 87 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 3 |
News Archive
BioCryst Pharmaceuticals, Inc. today announced that it has signed agreements with two additional partners who will exclusively represent BioCryst and its anti-viral peramivir for influenza stockpiling opportunities for territories outside of the U.S. BioCryst's new partners are Merck Serono for Europe, Russia, Canada and Singapore and Hikma Pharmaceuticals PLC for the Middle East and North Africa (MENA) region, excluding Israel.
DePuy Synthes today announced the availability of Continuous Compression Implants to health care providers across Europe, the Middle East and Africa. The implants are designed to provide continuous, active compression throughout the healing process to treat a variety of reconstructive foot and ankle procedures, and provide more solutions for our patients and customers.
Premenopausal women who have type 1 diabetes should strongly consider preventive screening for osteoporosis, the researchers of a new study on bone density conclude in the February issue of Diabetes Care.
Top-notch molecular research swung into gear at Texas A&M University this week - literally. A crane lowered a high-field 800 megahertz Nuclear Magnetic Resonance spectrometer through an opening in the roof of a biochemistry and biophysics building Wednesday, putting the university on par with leading U.S. research institutions, according to Dr. Gregory Reinhart, department head.
› Verified 2 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 28 |
| Hospitalization Rate in facility | 208.2 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 390.4 |
| Hospitalization Rate: Lower Confidence Limit | 116.7 |
News Archive
BioCryst Pharmaceuticals, Inc. today announced that it has signed agreements with two additional partners who will exclusively represent BioCryst and its anti-viral peramivir for influenza stockpiling opportunities for territories outside of the U.S. BioCryst's new partners are Merck Serono for Europe, Russia, Canada and Singapore and Hikma Pharmaceuticals PLC for the Middle East and North Africa (MENA) region, excluding Israel.
DePuy Synthes today announced the availability of Continuous Compression Implants to health care providers across Europe, the Middle East and Africa. The implants are designed to provide continuous, active compression throughout the healing process to treat a variety of reconstructive foot and ankle procedures, and provide more solutions for our patients and customers.
Premenopausal women who have type 1 diabetes should strongly consider preventive screening for osteoporosis, the researchers of a new study on bone density conclude in the February issue of Diabetes Care.
Top-notch molecular research swung into gear at Texas A&M University this week - literally. A crane lowered a high-field 800 megahertz Nuclear Magnetic Resonance spectrometer through an opening in the roof of a biochemistry and biophysics building Wednesday, putting the university on par with leading U.S. research institutions, according to Dr. Gregory Reinhart, department head.
› Verified 2 days ago
The rate of readmission show you whether patients who were being treated regularly at ARA Woodbridge Dialysis Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 26.2 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 35.7 |
| Readmission Rate: Lower Confidence Limit | 17.7 |
News Archive
BioCryst Pharmaceuticals, Inc. today announced that it has signed agreements with two additional partners who will exclusively represent BioCryst and its anti-viral peramivir for influenza stockpiling opportunities for territories outside of the U.S. BioCryst's new partners are Merck Serono for Europe, Russia, Canada and Singapore and Hikma Pharmaceuticals PLC for the Middle East and North Africa (MENA) region, excluding Israel.
DePuy Synthes today announced the availability of Continuous Compression Implants to health care providers across Europe, the Middle East and Africa. The implants are designed to provide continuous, active compression throughout the healing process to treat a variety of reconstructive foot and ankle procedures, and provide more solutions for our patients and customers.
Premenopausal women who have type 1 diabetes should strongly consider preventive screening for osteoporosis, the researchers of a new study on bone density conclude in the February issue of Diabetes Care.
Top-notch molecular research swung into gear at Texas A&M University this week - literally. A crane lowered a high-field 800 megahertz Nuclear Magnetic Resonance spectrometer through an opening in the roof of a biochemistry and biophysics building Wednesday, putting the university on par with leading U.S. research institutions, according to Dr. Gregory Reinhart, department head.
› Verified 2 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at ARA Woodbridge Dialysis Center get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .55 (As Expected) |
| SIR: Upper Confidence Limit | 2.73 |
| SIR: Lower Confidence Limit | .03 |
News Archive
BioCryst Pharmaceuticals, Inc. today announced that it has signed agreements with two additional partners who will exclusively represent BioCryst and its anti-viral peramivir for influenza stockpiling opportunities for territories outside of the U.S. BioCryst's new partners are Merck Serono for Europe, Russia, Canada and Singapore and Hikma Pharmaceuticals PLC for the Middle East and North Africa (MENA) region, excluding Israel.
DePuy Synthes today announced the availability of Continuous Compression Implants to health care providers across Europe, the Middle East and Africa. The implants are designed to provide continuous, active compression throughout the healing process to treat a variety of reconstructive foot and ankle procedures, and provide more solutions for our patients and customers.
Premenopausal women who have type 1 diabetes should strongly consider preventive screening for osteoporosis, the researchers of a new study on bone density conclude in the February issue of Diabetes Care.
Top-notch molecular research swung into gear at Texas A&M University this week - literally. A crane lowered a high-field 800 megahertz Nuclear Magnetic Resonance spectrometer through an opening in the roof of a biochemistry and biophysics building Wednesday, putting the university on par with leading U.S. research institutions, according to Dr. Gregory Reinhart, department head.
› Verified 2 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether ARA Woodbridge Dialysis Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 14 |
| Transfusion Rate in facility | (Not Available) |
| Transfusion Rate: Upper Confidence Limit | |
| Transfusion Rate: Lower Confidence Limit |
News Archive
BioCryst Pharmaceuticals, Inc. today announced that it has signed agreements with two additional partners who will exclusively represent BioCryst and its anti-viral peramivir for influenza stockpiling opportunities for territories outside of the U.S. BioCryst's new partners are Merck Serono for Europe, Russia, Canada and Singapore and Hikma Pharmaceuticals PLC for the Middle East and North Africa (MENA) region, excluding Israel.
DePuy Synthes today announced the availability of Continuous Compression Implants to health care providers across Europe, the Middle East and Africa. The implants are designed to provide continuous, active compression throughout the healing process to treat a variety of reconstructive foot and ankle procedures, and provide more solutions for our patients and customers.
Premenopausal women who have type 1 diabetes should strongly consider preventive screening for osteoporosis, the researchers of a new study on bone density conclude in the February issue of Diabetes Care.
Top-notch molecular research swung into gear at Texas A&M University this week - literally. A crane lowered a high-field 800 megahertz Nuclear Magnetic Resonance spectrometer through an opening in the roof of a biochemistry and biophysics building Wednesday, putting the university on par with leading U.S. research institutions, according to Dr. Gregory Reinhart, department head.
› Verified 2 days ago
The rate of mortality show you whether patients who were being treated regularly at ARA Woodbridge Dialysis Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 65 |
| Mortality Rate in facility | 13.3 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 34 |
| Mortality Rate: Lower Confidence Limit | 3.6 |
News Archive
BioCryst Pharmaceuticals, Inc. today announced that it has signed agreements with two additional partners who will exclusively represent BioCryst and its anti-viral peramivir for influenza stockpiling opportunities for territories outside of the U.S. BioCryst's new partners are Merck Serono for Europe, Russia, Canada and Singapore and Hikma Pharmaceuticals PLC for the Middle East and North Africa (MENA) region, excluding Israel.
DePuy Synthes today announced the availability of Continuous Compression Implants to health care providers across Europe, the Middle East and Africa. The implants are designed to provide continuous, active compression throughout the healing process to treat a variety of reconstructive foot and ankle procedures, and provide more solutions for our patients and customers.
Premenopausal women who have type 1 diabetes should strongly consider preventive screening for osteoporosis, the researchers of a new study on bone density conclude in the February issue of Diabetes Care.
Top-notch molecular research swung into gear at Texas A&M University this week - literally. A crane lowered a high-field 800 megahertz Nuclear Magnetic Resonance spectrometer through an opening in the roof of a biochemistry and biophysics building Wednesday, putting the university on par with leading U.S. research institutions, according to Dr. Gregory Reinhart, department head.
› Verified 2 days ago
Woodbridge Dialysis Center Location: 541 Main Street, Woodbridge, New Jersey, 07095 Phone: (732) 750-0639 |
ARA Woodbridge Dialysis Center Location: 345 Main Street, Woodbridge, New Jersey, 07095 Phone: (732) 855-2100 |
News Archive
BioCryst Pharmaceuticals, Inc. today announced that it has signed agreements with two additional partners who will exclusively represent BioCryst and its anti-viral peramivir for influenza stockpiling opportunities for territories outside of the U.S. BioCryst's new partners are Merck Serono for Europe, Russia, Canada and Singapore and Hikma Pharmaceuticals PLC for the Middle East and North Africa (MENA) region, excluding Israel.
DePuy Synthes today announced the availability of Continuous Compression Implants to health care providers across Europe, the Middle East and Africa. The implants are designed to provide continuous, active compression throughout the healing process to treat a variety of reconstructive foot and ankle procedures, and provide more solutions for our patients and customers.
Premenopausal women who have type 1 diabetes should strongly consider preventive screening for osteoporosis, the researchers of a new study on bone density conclude in the February issue of Diabetes Care.
Top-notch molecular research swung into gear at Texas A&M University this week - literally. A crane lowered a high-field 800 megahertz Nuclear Magnetic Resonance spectrometer through an opening in the roof of a biochemistry and biophysics building Wednesday, putting the university on par with leading U.S. research institutions, according to Dr. Gregory Reinhart, department head.
› Verified 2 days ago